Show simple item record

dc.contributor.authorBagir, Gulay Simsek
dc.contributor.authorBakiner, Okan S.
dc.contributor.authorBozkirli, Emre
dc.contributor.authorCavlak, Gulhan
dc.contributor.authorSerinoz, Hulya
dc.contributor.authorErtorer, M. Eda
dc.date.accessioned2019-09-19T08:38:47Z
dc.date.available2019-09-19T08:38:47Z
dc.date.issued2016
dc.identifier.issn1011-7571
dc.identifier.urihttps://www.karger.com/Article/Pdf/440810
dc.identifier.urihttp://hdl.handle.net/11727/3962
dc.description.abstractObjective: The aim of this study was to determine the cardiometabolic risk factors in different polycystic ovary syndrome (PCOS) phenotypes. Subjects and Methods: This cross-sectional study was performed between 2010 and 2011. Eighty-nine patients with PCOS and 25 age- and weight-matched healthy controls were included in the study. Patients were grouped using the Rotterdam 2003 criteria as: group 1, oligomenorrhea and/or anovulation (ANOV) and hyperandrogenemia (HA) and/or hyperandrogenism (n = 23); group 2, ANOV and polycystic ovaries (PCO; n = 22); group 3, HA and PCO (n = 22); group 4, ANOV, HA and PCO (n = 22); group 5, controls (n = 25). Laboratory blood tests for diagnosis and cardiometabolic risk assessments were performed. Insulin resistance (IR) was calculated in all patients with the homeostasis model assessment of IR (HOMA-IR) formula. An euglycemic hyperinsulinemic clamp test was performed on 5 randomly selected cases in each subgroup, making 25 cases in total, and indicated as the 'M' value (mg/kg/min), which is the total body glucose disposal rate. Results: The mean BMl values of the groups were: group 1, 26.1 +/- 5.3; group 2, 27.9 +/- 5.2; group 3, 24.3 +/- 4.2; group 4, 27.9 +/- 7.5; group 5, 24.7 +/- 5.2 (p > 0.05). There were no differences in the lipid profile, plasma glucose, HOMA-IR, insulin and M values between the groups (p > 0.05). Phenotypes with oligomenorrhea/anovulation (groups 1, 2 and 4) were more obese than group 3 (p = 0.039). Conclusions: The cardiometabolic risk profile was similar among the PCOS subgroups. This finding could be attributed to the mean BMl values, which, being below 30, were not within the obesity range. Obesity appeared to be an important determinant of high cardiovascular risk in PCOS. (C) 2015 S. Karger AG, Baselen_US
dc.language.isoengen_US
dc.relation.isversionof10.1159/000440810en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectPolycystic ovary syndromeen_US
dc.subjectCardiovascular systemen_US
dc.subjectObesityen_US
dc.titleBody Mass Index below Obesity Threshold Implies Similar Cardiovascular Risk among Various Polycystic Ovary Syndrome Phenotypesen_US
dc.typearticleen_US
dc.relation.journalMEDICAL PRINCIPLES AND PRACTICEen_US
dc.identifier.volume25en_US
dc.identifier.issue1en_US
dc.identifier.startpage61en_US
dc.identifier.endpage66en_US
dc.identifier.wos000368075600012


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record